|
| |
ADVANCE PROGRAM
|
MONDAY, OCTOBER 2, 2000
|
| 14:00 - 15:45 |
Hall A |
| PL01: |
INTERVENTIONAL CARDIOLOGY: WHERE DO WE
STAND?
Chairperson: T.A. Bass, Jacksonville Fl, USA
I.K. De Scheerder, Leuven, Belgium |
| 14:00 |
THE CONTRIBUTION OF STENTS TO ENDOLUMINAL
THERAPY (Invited Lecture)
U. Sigwart, London, UK |
| 14:15 |
PREVENTION OF IN-STENT RESTENOSIS (Invited
Lecture)
I. De Scheerder, Leuven, Belgium |
| 14:30 |
IS IT THE END OF CORONARY ARTERY ANGIOPLASTY
? (Invited Lecture)
J. Puel, Toulouse, France |
| 14:45 |
TRANSRADIAL CORONARY INTERVENTION (Invited
Lecture)
S. Saito, Kamakura, Japan |
| 15:00 |
CATHETER BASED TREATMENT OF CAROTID STENOSES
IN HIGH RISK CARDIOVASCULAR PATIENTS (Invited Lecture)
T.A. Ischinger, Munich, Germany |
| 15:15 |
TEN YEAR CLINICAL AND ANGIOGRAPHIC FOLLOW-UP
AFTER PTCA (Invited Lecture)
M. Nobuyoshi, Kitakyushu, Japan |
| 15:30 |
14 YEAR SURVIVAL AND OUTCOME EVENTS IN
PATIENTS UNDERGOING PERCUTANEOUS OR SURGICAL MYOCARDIAL
REVASCULARIZATION (Invited Lecture)
D.A. Halon, M.Y. Flugelman, H.S. Rennert, A. Merdler, N. Khader, J.
Shahla, B.S. Lewis, Haifa, Israel |
| 15:45 |
NEW STENT DESIGNS FOR BIFURCATION LESIONS
(Invited Lecture)
S. Windecker, W. Maier, F. Buddeberg, B. Meier, O.M. Hess, Bern,
Switzerland |
| 16:00 |
C o f f e e B r e a k |
| 14:00 - 15:45 |
Hall B |
| PL02: |
EPIDEMIOLOGY AND PREVENTION OF CORONARY
ARTERY DISEASE
Chairpersons: I.M. Graham, Dublin, IrelandS.N. Willich,
Berlin, Germany |
| 14:00 |
CARDIOLOGY IN THE NEW MILLENNIUM:
PREVENTIVE STRATEGIES FOR A GLOBAL EPIDEMIC (Invited Lecture)
S.C. Smith, Chapel Hill NC, USA |
| 14:15 |
EMERGING TRENDS IN CARDIOVASCULAR RISK
FACTORS IN MEN AND WOMEN (Invited Lecture)
A. Rosengren, Goteborg, Sweden |
| 14:30 |
ETHICAL DILEMMAS IN DECISION MAKING FOR PREVENTION
AND TREATMENT OF CORONARY ARTERY DISEASE (Invited Lecture)
H.J. Geschwind, Creteil, France |
| 14:45 |
GENE-ENVIRONMENT INTERACTIONS IN CORONARY
ARTERY DISEASE (Invited Lecture)
A. Evans, Belfast, Ireland |
| 15:00 |
HOMOCYSTEINE AS A RISK
FACTOR FOR CORONARY ARTERY DISEASE - CAUSE OR EFFECT? (Invited
Lecture)
I.M. Graham, Dublin, Ireland |
| 15:15 |
TREATMENT GOALS ACHIEVED IN PATIENTS AT
HIGH RISK FOR ATHEROSCLEROTIC DISEASE TREATED IN GENERAL
PRACTICE
A. Svilaas, K. Risberg, M. Thoresen, L. Ose,
Oslo, Norway |
| 15:30 |
NEW INSIGHTS ABOUT THE INTERACTION OF TRIGLYCERIDES
AND HDL AFFECTING CORONARY RISK (Invited Lecture)
S.L. Tokgozoglu, Ankara, Turkey |
| 15:45 |
CORONARY ARTERY ECTASIA (Invited Lecture)
D.V. Cokkinos, V.P. Demopoulos, V. Voudris, A. Manginas,
P. Cotileas, S.G. Foussas, M. Papadakis, Athens, Greece |
|
16:00 |
C o f f e e B r e a k |
| 14:00 - 15:45 |
Hall C |
| S51: |
VASCULAR BIOLOGY
Chairpersons: E.L. Bassenge, Freiburg, GermanyM.Y. Flugelman,
Haifa, Israel |
| 14:00 |
IMMUNOHISTOCHEMICAL (IHC), IN SITU
HYBRIDISATION (ISH) AND BIOCHEMICAL CHARACTERISATION OF PHOSPHODIESTERASE
TYPE 5 (PDE5) IN NORMAL AND ISCHAEMIC HUMAN CARDIAC TISSUE
D.V. Parums, R.G. Charlton, N. Johnson, T. Cindrova,
S. Phillips, J. Ridden, F.M. Burslem,
Sandwich, UK |
| 14:15 |
SECOND HAND SMOKE CAUSES VASCULAR
DYSFUNCTION IN UTERO
S.J. Hutchison,
K. Sudhir, T.M. Chou, K. Chatterjee, P.C. Deedwania,
W.W. Parmley, Toronto ON, Canada |
| 14:30 |
MCP-1 CHEMOKINE IN PATIENTS WITH
PERIPHERAL ARTERIAL DISEASE
J. Petrkova,
M. Petrek, M. Scudlova, J. Szotkowska, E. Weigl, J. Lukl,
Olomouc, Czech Republic |
| 14:45 |
HOMOCYSTEINE-LOWERING IMPROVES RESISTANCE
VESSEL REACTIVITY IN PATIENTS WITH CORONARY ARTERY DISEASE
O. Stanger,
H. Semmelrock, W. Wonisch, M. Lemmerer, B. Rigler,
T. Wascher, Graz, Austria |
| 15:00 |
ENDOTHELIUM-DERIVED HYPERPOLARIZING FACTOR
MAINTAINS A NORMAL RELAXATION TO BRADYKININ DESPITE THE REDUCED
PRODUCTION OF NITRIC OXIDE IN PORCINE CORONARY ARTERIES AFTER
ANGIOPLASTY
C. Thollon, M.P. Fournet-Bourguignon, L. Lesage, D. Saboureau, C. Cambarrat,
H. Reure, P.M. Vanhoutte, J.P. Vilaine, Suresnes, France |
| 15:15 |
IN PTCA: OPTIMAL SUPPRESSION OF THROMBOXANE,
BUT NOT 8-EPI PGF2a, WITH ASPIRIN. NO ADDITIONAL BENEFIT FROM COX-2
INHIBITION
D. Kearney,
A. Byrne, P. Crean, D. Fitzgerald, Dublin, Ireland |
| 15:30 |
EVIDENCE OF MICROVASCULAR DYSFUNCTION
IN SYNDROME X PATIENTS WITH TIMI FRAME COUNT METHOD
E. Rentoukas,
G. Lazaros, S. Deftereos, M.G. Foukarakis, N. Kouvousis,
G. Giannouleas, A. Zacharoulis, Athens, Greece |
| 15:45 |
APOPTOSIS AND CELL PROLIFERATION: REGIONAL
RESPONSE TO PTCA INJURY
N. Malik,
J. Gunn, S.E. Francis, C.M. Holt, L. Shepherd,
C.M.H. Newman, D.C. Cumberland, D.C. Crossman, Sheffield,
UK |
| 16:00 |
C o f f e e B r e a k |
|
